Organization
ArQule, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
ArQule, Inc.
... oncology pipeline In April 2018, Basilea entered into a license agreement with ArQule, Inc., for its late-stage oncology drug candidate derazantinib (BAL087), which targets the ...
... + 211.4 16 ShotSpotter n 45.22 14.00 42.67 +28.62 + 203.7 17 ArQule 7.21 1.46 4.98 + 3.33 + 201.8 18 LegacyRs pfB 19.24 4.42 ...
... + 269.6 10 Fossil Grp 32.17 7.16 26.87 +19.10 + 245.8 11 ArQule 6.07 1.46 5.53 + 3.88 + 235.2 12 XenonPharm 11.00 2.70 9.20 ...
... Qudian Inc. (NYSE:QD), ICICI Bank Limited (NYSE:IBN), Mobile TeleSystems OJSC (NYSE:MBT), ArQule, Inc. (NASDAQ:ARQL), Alibaba Group Holding Limited (NYSE:BABA), and Arcos Dorados Holdings Inc. (NYSE:ARCO), ...
... ArQule, Inc. appointed Dr. Marc Schegerin as senior vice president, corporate strategy, communication ...
... also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ...
Subscribe now for full coverage on ArQule, Inc.
Start My Free Trial